Canada's MindWalk Q4 revenue misses estimates
HYFT•Buyback authorization and outlook
The company authorized a share repurchase program for up to 2.3 million shares, or about 5% of shares outstanding.
MindWalk did not provide specific guidance for the current quarter or full year.
Quarterly revenue missed estimates
Canada's MindWalk reported fourth-quarter revenue of C$4.1 million, below analyst expectations of C$4.41 million from three analysts. Fourth-quarter net loss was C$3.87 million, and gross profit was C$2.5 million.
Fiscal 2026 revenue rose as company completed pivot
Fiscal 2026 revenue rose 46% year over year as the company said growth was driven by completion of its pivot to BioIntelligence infrastructure and deployment of HYFT Technology. The company also said it signed its first two contracted, recurring enterprise LensAI agreements, contributing to revenue growth.
Lower operating expenses reflected the non-recurrence of prior-year non-cash amortization and impairment charges.
